EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
about
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse modelIn vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donorsTonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.A complex role of herpes viruses in the disease process of multiple sclerosis.Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityPersistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management.Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCsEpstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target.Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cellsEpstein-barr virus: environmental trigger of multiple sclerosis?Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infectionsAcquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro.Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cellsTargeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferationIncreased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaquesImmune escape by Epstein-Barr virus associated malignancies.The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis.Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Prospects of a novel vaccination strategy for human gamma-herpesviruses.Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant.Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clonesDifferential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infectionEpstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.
P2860
Q24657388-B3CFE670-492D-4AAE-AEFB-4247A90BAF8DQ27003380-7DAD62B2-E205-4198-8723-0319173FED24Q28362603-107352B9-1FE6-49A5-9837-E2D8D0330D25Q33319277-1A2586CC-415E-45DD-AB34-6D429F0E90A5Q34078589-25A2F016-432E-4D9E-A3BB-7CDD674113AAQ34186587-C6A40A6B-6709-4B87-99B6-43702B12CBE0Q34602196-6304F0B4-C43D-4CE6-98D2-50907913C0D9Q34861980-4B106775-F28F-4EA4-9585-39616EE5515AQ35616090-3B7C5AB3-536E-47F8-878B-3C9227EE87D5Q35645903-BA7708F6-769C-411A-942F-138234083549Q35775750-633C4C03-A254-4052-AA2B-A52E3F8C8BDDQ35857336-027AC1F8-FF55-4FD9-9A46-69D547BC666CQ35914342-612D0B5A-49E9-44EC-8B8C-88622596DDBDQ36142490-1DBE6755-F756-451D-A1A2-D0D0640157EBQ36228210-F828CBEE-FC8F-4D98-A385-16BFECBBF49EQ36371518-51D3B7B8-B55D-4003-960C-5969C36BE155Q36376233-E258BFB8-649C-4F7F-8413-13B0A2615863Q36835091-FD74A3AF-288B-45EF-8CE2-C46D772ECCB5Q36890569-AF8307FF-AC97-4FDC-8B4A-3D30D1563312Q36943860-580EEC77-70DE-4757-B44C-603912F1878FQ37019458-88CF4BD1-4AE8-45CC-A143-1343DC230D94Q37036688-C966D299-BE99-4D70-A372-0801C5AA62D2Q37041507-2735365A-96EE-443D-95C1-A4F76CC87210Q37089835-48F25C68-D9F0-487F-B359-E639AB98EF2DQ37139813-062E5C5B-758D-43C6-9486-D9E139AA8176Q37178988-D900D62C-5EAA-4E27-AD57-C667618F51FCQ37286445-EB617799-2074-491F-AA41-B4E928CFBDC7Q37336847-943D3FBD-A8D9-49B4-A238-1DF75FEA2190Q37667998-75D007FC-703A-4783-A33B-DF550FCC4C8DQ37773234-9DDA219C-D4E1-4382-9F43-B495B2378B3EQ37780705-77464FB1-4177-499D-9D0D-4DBDA9ECFAB1Q38759383-CA1C047B-E91D-421E-A02D-D0F4187887CAQ39604412-F4A8C602-19CE-4ADB-B86C-83338956C62AQ39607047-F390CC0B-66EE-4FE5-A05D-5CB23855CB69Q40471906-844C16EF-4608-488C-B28C-8CF332A2E2E6Q40909600-60B8CA20-7B57-40D9-B7F0-491BDF259859Q45365121-47199BC6-37CF-489E-9201-BB35E7476A26Q49787173-424ED876-0CFC-435F-A8A6-CC3428001F42Q54545163-E1845000-2104-4B05-8BF0-8D13F12EDA5F
P2860
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@ast
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@en
type
label
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@ast
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@en
prefLabel
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@ast
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@en
P2093
P2860
P356
P1476
EBNA1-specific CD4+ T cells in ...... are primarily Th1 in function
@en
P2093
P2860
P304
P356
10.1172/JCI10209
P407
P577
2001-01-01T00:00:00Z